ChienYW. Pharmaceutical considerations of transdermal nitroglycerin delivery: The various approaches. Am Heart J1984; 108: 207–16.
2.
ThompsonRH. The clinical use of transdermal delivery devices with nitroglycerin. Angiology1983; 34: 23–31.
3.
CreanPARibeiroPCreaFDaviesGJRatcliffeDMaseriA. Continuous transdermal nitroglycerin administration in the treatment of chronic angina pectoris (abstract). Circulation1983; 68 (suppl III): III–405.
4.
ReichekNPriestCZimrinDChandlerTSuttonMSJ. Antianginal effects of nitroglycerin patches. Am J Cardiol1984; 54: 1–7.
5.
ParkerJO. Transdermal nitroglycerin in angina pectoris. Am J Cardiol1984; 54:(in press).
6.
ParkerJOVanKoughnettKAFungHL. Transdermal isosorbide dinitrate in angina pectoris: Effect of acute and sustained therapy. Am J Cardiol1984; 54: 8–13.
7.
HollenbergMGoM. Clinical studies with transdermal nitroglycerin. Am Heart J1984; 108: 223–31.
8.
AbramsJ. The brief saga of transdermal nitroglycerin discs: Paradise lost? (editorial)Am J Cardiol1984; 54: 220–4.
9.
MullerPImhoffPRBurkartFChuLCGerardinA. Human pharmacological studies of a new transdermal system containing nitroglycerin. Eur J Clin Pharmacol1982; 22: 473–80.
10.
RajferSIDemmaFJGoldbergLI. Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin. Am J Cardiol1984; 54: 120–5.
11.
OlivariMTCarlylePFLevineTBCohnJN. Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure. J Am Coll Cardiol1983; 2: 872–8.
12.
SharpeDNCoxonR. Nitroglycerin in a transdermal therapeutic system in chronic heart failure. J Cardiovasc Pharmacol1984; 6: 76–82.